Amgen's R&D next podcast series Innovating Clinical Trials is now available wherever you listen to podcasts. Produced in partnership with The Scientist, Innovating Clinical Trials explores the latest in clinical trial design and execution, including real-world examples of how researchers in our industry can run trials better and faster to develop optimal medicines that benefit more patients.
Because clinical trials are complex and multidisciplinary, there is not a single, simple solution. What does innovation in clinical trials look like? In this series, host Rob Lenz, M.D., Ph.D, Amgen's senior vice president of Global Development, and experts leading next-generation clinical trials explore trends and drivers in design and execution to improve trial quality and safety, decrease costs, and improve predictability, reliability, and speed.
"Our understanding of human biology and disease is progressing at an unprecedented pace, and clinical trial development and execution needs to evolve just as quickly to deliver potentially lifesaving medicines to patients who can't wait," said Lenz. "Indeed, innovation within clinical trials is accelerating like never before. The new podcast series, Innovating Clinical Trials, gives an inside view of how the industry can bring trials closer to patients and include broader representation of patients likely to benefit from new medicines."
The first episode launches Sept. 1, and the series continues with a new episode every Thursday through Sept. 22. You can find Innovating Clinical Trials here or by subscribing to The Scientist's series LabTalk on Apple Podcasts, Spotify, Stitcher, Google Podcasts, or wherever you like to listen.
September 1: Operational Innovation
Dr. Cynthia Verst, President, Design and Delivery Innovation, R&D Solutions at IQVIA
September 9: Real-World Data in Drug Development
Brian D. Bradbury, D.Sc., Vice President, Center for Observational Research at Amgen
September 16: The Right Patients
Dr. Ponda Motsepe-Ditshego, Vice President and Therapeutic Area Head of Global Medical, General Medicine at Amgen
September 23: Real-World Clinical Trial Design and Execution in Oncology
David Raben, M.D., Vice President Global Development & Product General Manager, Oncology at Amgen
In addition to the podcast series, Amgen and The Scientist will offer a live webinar with Taras Carpiac, executive director of clinical trial process improvement at Amgen, to dig deeper into the latest trends in clinical trial design and execution. Register to listen here.
Innovating Clinical Trials is the fourth podcast series Amgen is hosting in partnership with The Scientist. You can find the first three series, DNA Unlocked, Undruggable and Generative Biology Revolution, here.
